Tesamorelin
★ 75 FDA approvedTesamorelin (Egrifta)
GHRH analog targeting visceral fat
Fat LossAbout
FDA-approved GHRH analog, used in HIV lipodystrophy. Highly effective for visceral fat reduction.
Mechanism
GHRH analog with a longer half-life, stimulating the GH/IGF-1 axis.
Dosage
beginner
- Amount
- 1 mg
- Frequency
- 1x per day before sleep
- Route
- SubQ
- Duration
- 12 weeks
standard
- Amount
- 2 mg
- Frequency
- 1x per day before sleep
- Route
- SubQ
- Duration
- 16-26 weeks
advanced
- Amount
- 2 mg + 1 mg AM
- Frequency
- Split into two doses
- Route
- SubQ
- Duration
- 26 weeks
On an empty stomach before sleep (30-60 min prior).
16-26 weeks on, 4-8 weeks off
Reconstitution & Storage
Fragile — always store refrigerated after reconstitution.
Dosing reference — units to draw
Concentration = peptide mass ÷ bacteriostatic water; units to draw = dose volume (mL) × 100 on a U-100 insulin syringe. Each vial size below is shown at 1 mL, with the units to draw for a typical 1–2 mg dose.
| Vial | BAC water | Concentration | Units to draw |
|---|---|---|---|
| 10 mg | 1 mL | 10 mg/mL | 10–20 units |
Lyophilized: refrigerated. Reconstituted: 2-8°C, 7 days.
Benefits
- • Significant visceral fat reduction
- • Improved lipid profile
- • Increased IGF-1
- • Muscle building
- • Improved energy
Side effects
- • Facial flushing
- • Tingling
- • Fluid retention
- • Joint pain
- • Rare: elevated blood glucose
Contraindications
- • Pituitary disease
- • Active cancer
- • Pregnancy
- • Diabetes (requires monitoring)
Gender notes
Men
Same dose. Best for middle-age belly fat.
Women
Same dose, 1-2 mg. Highly effective for post-menopausal belly fat.
Research
- Falutz J et al: Tesamorelin reduces visceral fat in HIV ↗
26-week study, 15% reduction in visceral fat vs placebo.
New England Journal of Medicine · 2007
- Stanley TL et al: Tesamorelin and NAFLD ↗
Tesamorelin reduces fatty liver independent of HIV status.
The Lancet HIV · 2019
Stacks well with
Tesamorelin FAQ
How do you reconstitute Tesamorelin?
Add 1 mL of bacteriostatic water to a 10 mg vial of Tesamorelin, which gives a concentration of 10 mg/mL. Inject the water slowly down the vial wall and swirl gently — never shake.
What is a typical Tesamorelin dose?
A typical research dose of Tesamorelin is 1–2 mg, 1x per day before sleep. This is educational information, not medical advice.
How many units of Tesamorelin do I draw?
From a 10 mg vial reconstituted with 1 mL of bacteriostatic water, draw 10–20 units on a U-100 insulin syringe for a 1–2 mg dose.
Track Tesamorelin doses in the app
Built-in reconstitution calculator, dose log, and reminders. Free on Android.
Get on Google PlayEducational use only. Not medical advice. Many peptides shown are not FDA-approved and remain research compounds. Always consult a qualified healthcare provider.